IL6 and polycystic ovary syndrome: on polycystic ovary syndrome-induced mice, LC in the dosage of 500 mg/kg for every second day demonstrated a significant reduction in IL-6, MDA, and tumor necrosis factor- α (TNF-α) in the intervention group versus control after 28 days [23].